Wettig Thane's Form 4 filing
Kyntra Bio, Inc. (KYNB) · filed Mar 25, 2025
- Accession no.
- 0001415889-25-008872
- Filed
- Mar 25, 2025, 9:00 AM ET
- Trade date
- Mar 24, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $50.7K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wettig ThaneCIK 0001815638 | Director, Officer (CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 24, 2025 | Common Stock | PPurchaseAcquired | +145,000 | $0.3494 | +$50,663 | 543,329 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.